Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.3K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.3K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.9K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.9K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.7K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

154
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
154
Drug Therapy01:28

Drug Therapy

184
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
184

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared burden of ultra-rare genetic variants across a spectrum of motor neuron diseases.

Translational neurodegeneration·2025
Same author

Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU).

Muscle & nerve·2023
Same author

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.

PloS one·2022
Same author

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study.

Neurology·2021
Same author

Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis.

EMBO molecular medicine·2020
Same author

A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1.

Muscle & nerve·2020
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Dec 7, 2025

Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.6K

Rising Drug Costs for Neurologic Diseases.

Jason L Crowell, Ted M Burns

    Continuum (Minneapolis, Minn.)
    |October 1, 2020
    PubMed
    Summary
    This summary is machine-generated.

    High prescription drug costs, particularly for orphan drugs, strain patients and society. Clinicians must discuss drug value and financial toxicity with patients to mitigate risks like bankruptcy and abandonment.

    Area of Science:

    • Health Economics
    • Pharmaceutical Policy
    • Clinical Therapeutics

    Background:

    More Related Videos

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.5K
    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
    08:25

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

    Published on: July 16, 2014

    11.1K

    Related Experiment Videos

    Last Updated: Dec 7, 2025

    Intracranial Pharmacotherapy and Pain Assays in Rodents
    02:26

    Intracranial Pharmacotherapy and Pain Assays in Rodents

    Published on: April 9, 2019

    5.6K
    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    14:55

    Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

    Published on: May 12, 2013

    61.5K
    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice
    08:25

    Heterotopic Mucosal Engrafting Procedure for Direct Drug Delivery to the Brain in Mice

    Published on: July 16, 2014

    11.1K
    • Rising prescription drug costs in the U.S. present a critical challenge for patients and healthcare systems.
    • Orphan drugs, while innovative for rare diseases, are often high-priced, leading to financial hardship.
    • The Orphan Drug Act (1983) successfully incentivized development but is now associated with pricing exploitation.